Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11822200rdf:typepubmed:Citationlld:pubmed
pubmed-article:11822200lifeskim:mentionsumls-concept:C0010682lld:lifeskim
pubmed-article:11822200lifeskim:mentionsumls-concept:C0023869lld:lifeskim
pubmed-article:11822200lifeskim:mentionsumls-concept:C0558287lld:lifeskim
pubmed-article:11822200lifeskim:mentionsumls-concept:C1521801lld:lifeskim
pubmed-article:11822200pubmed:issue4-6lld:pubmed
pubmed-article:11822200pubmed:dateCreated2002-2-1lld:pubmed
pubmed-article:11822200pubmed:abstractTextWe determined the efficacy of alpha-mercaptopropionyl-glycine administered in a low dosage continuously or every other day for prophylaxis of cystine calculosis. Two homozygous cystinuric patients with previous calculosis and renal unilateral hypoplasia and been given preventive treatment with alpha-mercaptopropionyl-glycine continuously administered in a low dosage (1.5-4 mg Kg-1 day-1 for 14 1/2 years and 10(-4) mg Kg-1 day-1 for 9 years respectively). Neither calculosis, nor side effects were observed. Subsequently, the patients were given 4 mg Kg-1 of the drug every second day for 1 and 1-2 years respectively without calculosis or side effect being observed. A low dosage of alpha-mercaptopropionyl-glycine(1.5-4 mg Kg-1 day-1) supplied continuously or, for a short time, 4 mg Kg-1 day-1 supplied every other day can be effective in the prophylaxis of cystine nephrolithiasis in some homozygous patients with renal unilateral hypoplasia, with lower risk of side effects.lld:pubmed
pubmed-article:11822200pubmed:languageenglld:pubmed
pubmed-article:11822200pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11822200pubmed:citationSubsetIMlld:pubmed
pubmed-article:11822200pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11822200pubmed:statusMEDLINElld:pubmed
pubmed-article:11822200pubmed:issn0037-8771lld:pubmed
pubmed-article:11822200pubmed:authorpubmed-author:BerioAAlld:pubmed
pubmed-article:11822200pubmed:authorpubmed-author:PiazziAAlld:pubmed
pubmed-article:11822200pubmed:issnTypePrintlld:pubmed
pubmed-article:11822200pubmed:volume77lld:pubmed
pubmed-article:11822200pubmed:ownerNLMlld:pubmed
pubmed-article:11822200pubmed:authorsCompleteYlld:pubmed
pubmed-article:11822200pubmed:pagination35-41lld:pubmed
pubmed-article:11822200pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:11822200pubmed:meshHeadingpubmed-meshheading:11822200...lld:pubmed
pubmed-article:11822200pubmed:meshHeadingpubmed-meshheading:11822200...lld:pubmed
pubmed-article:11822200pubmed:meshHeadingpubmed-meshheading:11822200...lld:pubmed
pubmed-article:11822200pubmed:meshHeadingpubmed-meshheading:11822200...lld:pubmed
pubmed-article:11822200pubmed:meshHeadingpubmed-meshheading:11822200...lld:pubmed
pubmed-article:11822200pubmed:meshHeadingpubmed-meshheading:11822200...lld:pubmed
pubmed-article:11822200pubmed:articleTitleProphylaxia of cystine calculosis by alpha-mercaptopropionyl-glycine administered continuously or every other day.lld:pubmed
pubmed-article:11822200pubmed:affiliationCattedra di Pediatria, Università di Genova.lld:pubmed
pubmed-article:11822200pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11822200pubmed:publicationTypeCase Reportslld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11822200lld:pubmed